Managing Scarcity: Innovation and Resilience During the COVID-19 Pandemic

Abstract

The Coronavirus Disease 2019 (COVID-19) pandemic remains a disruptive force upon the health care system, with particular import for thoracic surgery given the pulmonary pathophysiology and disease implications of the virus. The rapid and severe onset of disease required expedient innovation and change in patient management and novel approaches to care delivery and nimbleness of workforce. In this review, we detail our approaches to patients with COVID-19, including those that required surgical intervention, our expedited and novel approach to bronchoscopy and tracheostomy, and our expansion of telehealth. The pandemic has created a unique opportunity to reflect on our delivery of care in thoracic surgery and apply lessons learned during this time to “rethink” how to optimize resources and deliver excellent and cutting-edge patient care.

Global research hotspots and trends in the field of spine surgery during the COVID-19 pandemic: A bibliometric and visual analysis

“…The recent coronavirus disease 2019 (COVID-19) pandemic was caused by a global rampant spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), sending the health systems into a state of emergency throughout the world (1)(2)(3). Patients with COVID-19 infection present with varying symptoms, ranging from sore throat, sneezing and runny nose, fever, cough, shortness of breath, fatigue, muscle pain, body aches, headache, nausea, and diarrhea to severe infection resulting in death (4)(5)(6). With subsequent mutations and infection with the novel Omicron variant, the normalization of outbreak prevention methods and controls has entered a new phase.…”